Literature DB >> 26764138

Histone acetylation and methylation significantly change with severity of atherosclerosis in human carotid plaques.

Anna Greißel1, Mihaela Culmes1, Rainer Burgkart2, Alexander Zimmermann1, Hans-Henning Eckstein1, Alma Zernecke3, Jaroslav Pelisek4.   

Abstract

BACKGROUND: The aim of the study was to analyze histone acetylation, methylation, and the expression of their corresponding transferases in atherosclerotic plaques of patients with carotid artery stenosis.
METHODS: Atherosclerotic tissue from our biobank (n=80) was divided into various segments covering all plaque stages and classified according to the American Heart Association. The plaques were assigned to early (types I-III) or advanced (types V-VII) stage group of atherosclerosis. Ten healthy carotid arteries from transplant donors served as controls. The expression of histone acetyltransferases (GNAT group: GCN5L, P300/CBP group: P300, MYST group: MYST1 and MYST2) and histone methyltransferases (H3K4: MLL2/4, SET7/9, and hSET1A; H3K9: SUV39H1, SUV39H2, ESET/SETDB1, and EHMT1; H3K27: EZH2 and G9a) was analyzed by SYBR-green-based real-time polymerase chain reaction. Histone acetylation/methylation in the cells within atherosclerotic plaques was determined by immunohistochemistry.
RESULTS: Increased histone acetylation was observed on H3K9 and H3K27 in smooth muscle cells (SMCs) in advanced atherosclerotic lesions compared to healthy vessels (P=.002 and .034). H3K9 acetylation in SMCs and macrophages was associated with plaque severity of atherosclerosis (P=.048 and <.001). Expression of GCN5L and MYST1 also correlated with the severity of atherosclerosis (P<.001). Methylation of H3K9 and H3K27 was significantly reduced in atherosclerotic plaques in SMCs and inflammatory cells (P<.001 and .026). Methylation on H3K4 was significantly associated with the severity of atherosclerosis. Expression of methyltransferase MLL2/4 was increased in advanced stages of atherosclerosis (P<.001).
CONCLUSIONS: Histone acetylation and methylation seem to play a decisive role in atherosclerosis, showing significant differences between healthy vessels and vessels at different stages of atherosclerosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Carotid artery; Epigenetics; Histone acetylation and methylation; Methyl- and acetyltransferases

Mesh:

Substances:

Year:  2015        PMID: 26764138     DOI: 10.1016/j.carpath.2015.11.001

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  33 in total

1.  Clinical epigenomics for cardiovascular disease: Diagnostics and therapies.

Authors:  Matthew A Fischer; Thomas M Vondriska
Journal:  J Mol Cell Cardiol       Date:  2021-02-06       Impact factor: 5.000

2.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

Review 3.  Epigenetic Mechanisms in Monocytes/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease.

Authors:  Frank M Davis; Katherine A Gallagher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

Review 4.  Macrophages in vascular inflammation and atherosclerosis.

Authors:  Clement Cochain; Alma Zernecke
Journal:  Pflugers Arch       Date:  2017-02-06       Impact factor: 3.657

Review 5.  Histone Lysine Methylation Modification and Its Role in Vascular Calcification.

Authors:  Ye-Chi Cao; Su-Kang Shan; Bei Guo; Chang-Chun Li; Fu-Xing-Zi Li; Ming-Hui Zheng; Qiu-Shuang Xu; Yi Wang; Li-Min Lei; Ke-Xin Tang; Wen-Lu Ou-Yang; Jia-Yue Duan; Yun-Yun Wu; Muhammad Hasnain Ehsan Ullah; Zhi-Ang Zhou; Feng Xu; Xiao Lin; Feng Wu; Xiao-Bo Liao; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

6.  Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis.

Authors:  Fengyan Jin; Jian Li; Jianfeng Guo; Thorsten R Doeppner; Dirk M Hermann; Gang Yao; Yun Dai
Journal:  Eur Heart J Open       Date:  2021-08-17

Review 7.  Histone Methylation and Oxidative Stress in Cardiovascular Diseases.

Authors:  Xin Yi; Qiu-Xia Zhu; Xing-Liang Wu; Tuan-Tuan Tan; Xue-Jun Jiang
Journal:  Oxid Med Cell Longev       Date:  2022-03-16       Impact factor: 6.543

8.  Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.

Authors:  Arul J Duraisamy; Manish Mishra; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-12-01       Impact factor: 4.799

Review 9.  DNA Methylation in Stroke. Update of Latest Advances.

Authors:  Jerzy Krupinski; Caty Carrera; Elena Muiño; Nuria Torres; Raid Al-Baradie; Natalia Cullell; Israel Fernandez-Cadenas
Journal:  Comput Struct Biotechnol J       Date:  2017-12-09       Impact factor: 7.271

10.  Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E-deficient mice.

Authors:  Xianjing Wei; Ying Zhang; Lianna Xie; Kaijun Wang; Xiaoqing Wang
Journal:  Exp Ther Med       Date:  2021-06-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.